Search

everythinglearnresearchcommunity

for

Search:↓

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Young women with PCOS and no other heart risk factors have normal heart function.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Severe male pattern hair loss is linked to lower hair density in the back of the head.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Higher homocysteine levels may predict hair loss severity.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that managing PCOS effectively requires considering ethnic differences, obesity's impact, and ethical concerns in treatment approaches.

AB+ blood group is more common in alopecia areata patients.